Ikena Oncology News

Ikena Oncology | 8-K: Current report

Jul 12 16:08 ET

Ikena Oncology | 8-K: Current report

Jun 10 16:11 ET

Ikena Oncology | 8-K: Current report

May 28 16:32 ET

Ikena Oncology | DEFA14A: Others

Apr 26 16:37 ET

Ikena Oncology | DEF 14A: Definitive information statements

Apr 26 16:26 ET

Ikena Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 07:52 ET

Ikena Oncology | 8-K: Current report

Feb 21 16:39 ET

Ikena Oncology | 8-K: Current report

Jan 18 00:00 ET

Ikena Oncology | 8-K: Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results

Nov 9, 2023 07:09 ET

Ikena Oncology | 8-K: Current report

Oct 11, 2023 17:10 ET

Ikena Oncology | DEF 14A: Definitive information statements

Sep 25, 2023 16:05 ET

Ikena Oncology | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Sep 15, 2023 16:05 ET

Ikena Oncology | S-3: Registration statement for specified transactions by certain issuers

Aug 18, 2023 16:02 ET

Ikena Oncology | 8-K: Current report

Aug 7, 2023 08:02 ET

Ikena Oncology | 8-K: Current report

Jun 30, 2023 17:15 ET

Ikena Oncology | 8-K: Current report

Jun 9, 2023 16:26 ET

Ikena Oncology | 8-K: Current report

May 15, 2023 09:09 ET

Ikena Oncology | DEFA14A: Others

Apr 28, 2023 08:20 ET

Ikena Oncology | DEF 14A: Definitive proxy statements

Apr 28, 2023 08:17 ET

Ikena Oncology | 8-K: Current report

Apr 17, 2023 09:14 ET